Results 291 to 300 of about 65,529 (332)

The development of a silage-based biorefinery to deliver the maximum nutritional benefit for human consumption from UK grasslands. [PDF]

Philos Trans R Soc Lond B Biol Sci
Kurhan S, Ding Y, Guler F, Olalere OA, Eze S, Mumbi AW, Vriesekoop F, Pittson H, Castro-Dominguez B, Leese H, Behrendt K, Green R, Chuck C.   +12 more
europepmc   +1 more source

Insights into the Regulatory Effect of Danggui Buxue Tang in Postpartum Dairy Cows Through an Integrated Analysis of Multi-Omics and Network Analysis. [PDF]

Life (Basel)
Yong K, Luo Z, Zhou Z, Huang Y, Zhang C, Cao S.   +5 more
europepmc   +1 more source

Niacin mitigates heat stress-induced reduction in performance of Taihe black-boned silky fowl through modulation of gut microorganisms and short-chain fatty acids. [PDF]

Front Vet Sci
Mei W, Chen C, Gao X, Zhang W, Hu Z, Qu M, Wan G, Xu L.   +7 more
europepmc   +1 more source

Engineering Antioxidants with Pharmacological Applications: Biotechnological Perspectives. [PDF]

Antioxidants (Basel)
Paraschiv M, Turcov D, Zbranca-Toporaş A, Ciubotaru BI, Grădinaru I, Galaction AI.   +5 more
europepmc   +1 more source

Integrated transcriptomic and metabolomic analyses uncover novel genetic targets for enhanced l-tryptophan production in <i>Corynebacterium glutamicum</i>. [PDF]

Synth Syst Biotechnol
Dong Y, Gao R, Qin N, Liu K, Liu Y, Chen Z.   +5 more
europepmc   +1 more source

Metabolic shifts in plasma amino acids and related metabolites in response to SGLT2 inhibition and hyperglycemia in type 1 diabetes. [PDF]

Physiol Rep
Kugathasan L, Ragi N, Debnath S, Sridhar VS, Maity S, Feng T, Treviño E, Perkins BA, Cherney DZI, Sharma K.   +9 more
europepmc   +1 more source

Genetic impairment of ketone body signalling is a prevalent contributor to human metabolic dysfunction

Yesian AR, Lam BYH, Kim HI, Day FR, Williamson A, Jia R, Lockhart S, Rainbow K, Kaimakis V, Antypa M, Saudek V, Jones J, Normand C, Semache M, Sabbagh L, Neville MJ, Araújo-Vilar D, Jéru I, Stevens KA, Kong JX, Granade ME, Amar N, Mazzocca M, Tveter KM, Buxton JM, James LC, Ong KK, Tadross JA, Karpe F, Savage DB, Fazakerley DJ, Wareham N, Perry JRB, Bence KK, Fortin J, O’Rahilly S, Liu X.   +36 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cholesteremia and Nicotinic Acid

Archives of Internal Medicine, 1957
Introduction Arteriosclerosis is by far the leading cause of heart disease in old age, 8 although it does not spare the young. 10,13,17 It also offers an increasing problem in psychogeriatrics, largely because of its progressive incidence with senescence and because of increasing longevity.
M. Demay, P. O. O'reilly, K. Kotlowski
openaire   +3 more sources

Nicotinic Acid in NIDDM

JAMA: The Journal of the American Medical Association, 1990
To the Editor.— Drs Garg and Grundy1continue to enhance our knowledge of the treatment of dyslipidemia in non—insulin-dependent diabetes mellitus (NIDDM) with a systematic evaluation of various treatment modalities for this disease. Their article, "Nicotinic Acid as Therapy for Dyslipidemia in Non—Insulin-Dependent Diabetes Mellitus," provides ...
Jere P. Segrest, Yaakov Henkin
openaire   +4 more sources

Dihydroxyanthranilic Acid as a Precursor of Nicotinic Acid

Nature, 1951
A MIXTURE of 400 mgm. of o-aminoveratric acid (prepared by the method of Pschorr and Sumuleanu1), 100 mgm. of red phosphorus and 8 ml. of hydriodic acid (sp. gr. 1.7) was heated in a sealed tube at 100° for eight hours and then at 105° for two hours. The hydriodic acid salt of 2-amino-3,4-dihydroxybenzoic acid crystallized on cooling. After filtration,
Fumio Itoh, Katashi Makino, Keiko Nishi
openaire   +3 more sources